BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24894841)

  • 1. A prospective study of serum metabolites and colorectal cancer risk.
    Cross AJ; Moore SC; Boca S; Huang WY; Xiong X; Stolzenberg-Solomon R; Sinha R; Sampson JN
    Cancer; 2014 Oct; 120(19):3049-57. PubMed ID: 24894841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer.
    Guertin KA; Loftfield E; Boca SM; Sampson JN; Moore SC; Xiao Q; Huang WY; Xiong X; Freedman ND; Cross AJ; Sinha R
    Am J Clin Nutr; 2015 May; 101(5):1000-11. PubMed ID: 25762808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
    Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolites of tobacco smoking and colorectal cancer risk.
    Cross AJ; Boca S; Freedman ND; Caporaso NE; Huang WY; Sinha R; Sampson JN; Moore SC
    Carcinogenesis; 2014 Jul; 35(7):1516-22. PubMed ID: 24648381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of blood metabolites associated with colorectal cancer risk.
    Shu X; Xiang YB; Rothman N; Yu D; Li HL; Yang G; Cai H; Ma X; Lan Q; Gao YT; Jia W; Shu XO; Zheng W
    Int J Cancer; 2018 Aug; 143(3):527-534. PubMed ID: 29479691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol Consumption-Related Metabolites in Relation to Colorectal Cancer and Adenoma: Two Case-Control Studies Using Serum Biomarkers.
    Troche JR; Mayne ST; Freedman ND; Shebl FM; Guertin KA; Cross AJ; Abnet CC
    PLoS One; 2016; 11(3):e0150962. PubMed ID: 26967509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations.
    Guertin KA; Moore SC; Sampson JN; Huang WY; Xiao Q; Stolzenberg-Solomon RZ; Sinha R; Cross AJ
    Am J Clin Nutr; 2014 Jul; 100(1):208-17. PubMed ID: 24740205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Investigation of Serum Metabolites, Coffee Drinking, Liver Cancer Incidence, and Liver Disease Mortality.
    Loftfield E; Rothwell JA; Sinha R; Keski-Rahkonen P; Robinot N; Albanes D; Weinstein SJ; Derkach A; Sampson J; Scalbert A; Freedman ND
    J Natl Cancer Inst; 2020 Mar; 112(3):286-294. PubMed ID: 31168595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
    Trabert B; Eldridge RC; Pfeiffer RM; Shiels MS; Kemp TJ; Guillemette C; Hartge P; Sherman ME; Brinton LA; Black A; Chaturvedi AK; Hildesheim A; Berndt SI; Safaeian M; Pinto L; Wentzensen N
    Int J Cancer; 2017 Feb; 140(3):600-610. PubMed ID: 27770434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.
    Zhang C; Zhou S; Chang H; Zhuang F; Shi Y; Chang L; Ai W; Du J; Liu W; Liu H; Zhou X; Wang Z; Hong T
    Dis Markers; 2021; 2021():6858809. PubMed ID: 34917201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry.
    Nishiumi S; Kobayashi T; Kawana S; Unno Y; Sakai T; Okamoto K; Yamada Y; Sudo K; Yamaji T; Saito Y; Kanemitsu Y; Okita NT; Saito H; Tsugane S; Azuma T; Ojima N; Yoshida M
    Oncotarget; 2017 Mar; 8(10):17115-17126. PubMed ID: 28179577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
    Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
    BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel serum metabolomics-based diagnostic approach for colorectal cancer.
    Nishiumi S; Kobayashi T; Ikeda A; Yoshie T; Kibi M; Izumi Y; Okuno T; Hayashi N; Kawano S; Takenawa T; Azuma T; Yoshida M
    PLoS One; 2012; 7(7):e40459. PubMed ID: 22792336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen metabolism and risk of breast cancer in postmenopausal women.
    Fuhrman BJ; Schairer C; Gail MH; Boyd-Morin J; Xu X; Sue LY; Buys SS; Isaacs C; Keefer LK; Veenstra TD; Berg CD; Hoover RN; Ziegler RG
    J Natl Cancer Inst; 2012 Feb; 104(4):326-39. PubMed ID: 22232133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of plasma C-peptide and colorectal cancer risk in men.
    Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
    J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional metabolomics and breast cancer risk in a prospective study.
    Playdon MC; Ziegler RG; Sampson JN; Stolzenberg-Solomon R; Thompson HJ; Irwin ML; Mayne ST; Hoover RN; Moore SC
    Am J Clin Nutr; 2017 Aug; 106(2):637-649. PubMed ID: 28659298
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
    Mazzone PJ; Wang XF; Beukemann M; Zhang Q; Seeley M; Mohney R; Holt T; Pappan KL
    J Thorac Oncol; 2016 Jan; 11(1):72-8. PubMed ID: 26762741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.
    Tarney CM; Wang G; Bateman NW; Conrads KA; Zhou M; Hood BL; Loffredo J; Tian C; Darcy KM; Hamilton CA; Casablanca Y; Lokshin A; Conrads TP; Maxwell GL
    Am J Obstet Gynecol; 2019 Nov; 221(5):472.e1-472.e10. PubMed ID: 31279844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Kunzmann AT; Coleman HG; Huang WY; Kitahara CM; Cantwell MM; Berndt SI
    Am J Clin Nutr; 2015 Oct; 102(4):881-90. PubMed ID: 26269366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.